Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · IEX Real-Time Price · USD
5.04
-0.06 (-1.18%)
At close: Apr 26, 2024, 4:00 PM
4.970
-0.070 (-1.39%)
After-hours: Apr 26, 2024, 5:30 PM EDT
Syros Pharmaceuticals Market Cap
Syros Pharmaceuticals has a market cap or net worth of $134.71 million as of April 26, 2024. Its market cap has increased by 147.63% in one year.
Market Cap
134.71M
Enterprise Value
55.14M
1-Year Change
147.63%
Ranking
Category
Stock Price
$5.04
Market Cap Chart
Since June 30, 2016, Syros Pharmaceuticals's market cap has decreased from $413.10M to $134.71M, a decrease of -67.39%. That is a compound annual growth rate of -13.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 134.90M | 0.60% |
Apr 24, 2024 | 134.10M | -1.40% |
Apr 23, 2024 | 136.00M | 3.03% |
Apr 22, 2024 | 132.00M | 9.91% |
Apr 19, 2024 | 120.10M | -3.84% |
Apr 18, 2024 | 124.90M | -7.62% |
Apr 17, 2024 | 135.20M | -8.09% |
Apr 16, 2024 | 147.10M | 3.96% |
Apr 15, 2024 | 141.50M | -0.77% |
Apr 12, 2024 | 142.60M | -8.94% |
Apr 11, 2024 | 156.60M | 7.04% |
Apr 10, 2024 | 146.30M | 0.55% |
Apr 9, 2024 | 145.50M | 22.27% |
Apr 8, 2024 | 119.00M | -3.64% |
Apr 5, 2024 | 123.50M | -3.14% |
Apr 4, 2024 | 127.50M | -3.19% |
Apr 3, 2024 | 131.70M | 7.42% |
Apr 2, 2024 | 122.60M | -8.03% |
Apr 1, 2024 | 133.30M | -5.80% |
Mar 28, 2024 | 141.50M | -8.41% |
Mar 27, 2024 | 154.50M | 17.31% |
Mar 26, 2024 | 131.70M | -2.30% |
Mar 25, 2024 | 134.80M | 2.04% |
Mar 22, 2024 | 132.10M | -1.12% |
Mar 21, 2024 | 133.60M | 0.15% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Repare Therapeutics | 141.73M |
Electromed | 141.04M |
Augmedix | 138.42M |
Delcath Systems | 137.55M |
Sagimet Biosciences | 136.59M |
Agenus | 135.31M |
Amylyx Pharmaceuticals | 132.18M |
Vaxart | 131.82M |